BSX Q3 2025 Earnings Call Transcript Released

BSX released its Q3 2025 earnings call transcript, with key executives including CEO Michael Mahoney and CFO Jonathan Monson providing insights. The call included details on organic revenue growth, guidance excluding the pending acquisition of Nalu Medical, and references to non-GAAP financial measures. The transcript is available on the company's Investor Relations website.

By Motley Fool Transcribing, The Motley Fool Wed, April 22, 2026 at 6:07 PM GMT+3 46 min read · Yahoo Finance · April 22, 2026, 15:07 UTC

Tickers: $BSX

Topics: conference call earnings financial results guidance revenue

Read the full article at Yahoo Finance

More World news

Pomerantz Law Firm Investigates Cumberland Pharmaceuticals Following Clinical Trial Results and Stock Decline PR Newswire · November 12, 2026, 15:05 UTC
Bybit Launches Fiat-to-Crypto Rewards Campaign with 80,000 USDT Weekly Prize Pool PR Newswire · November 12, 2026, 15:06 UTC
U.S. Existing Home Sales Decline More Than Expected in October Seeking Alpha · November 12, 2026, 15:03 UTC
Evolution PowerX Reports Q3 Revenue Growth and Positive GAAP EPS Seeking Alpha · November 12, 2026, 15:04 UTC
UBS Data Shows Trend-Following Funds Shift to Net Short Position on Global Equities Seeking Alpha · November 12, 2026, 15:00 UTC
Bridgemarq Real Estate Services Reports Q3 2026 Non-GAAP EPS of $0.07 and Revenue of $107.7M Seeking Alpha · November 12, 2026, 15:01 UTC
B. Riley Upgrades Anterix to Buy Following Spectrum Deal Optimism Seeking Alpha · November 12, 2026, 15:02 UTC
BK Technologies Reports Q3 2026 Revenue Growth Amid Production Disruptions Motley Fool · November 12, 2026, 14:57 UTC
Nio October Deliveries Decline Despite Strong Year-to-Date Growth Motley Fool · November 12, 2026, 15:00 UTC
Pomerantz Law Firm Investigates Iovance Biotherapeutics Following Clinical Trial Data Discrepancy PR Newswire · November 12, 2026, 15:00 UTC